GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
106 hedge funds and large institutions have $80.4M invested in Sanofi Contingent Value Rights in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
26% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 19
Holders
106
Holding in Top 10
1
Calls
$2K
Puts
–
Top Buyers
| 1 | +$440K | |
| 2 | +$330K | |
| 3 | +$28.3K | |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$14K |
| 5 |
NGA
New Generation Advisors
Manchester,
Massachusetts
|
+$13.2K |
Top Sellers
| 1 | -$683K | |
| 2 | -$484K | |
| 3 | -$139K | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$101K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
-$57.4K |